Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial

BACKGROUND: In the ABSOLUTE trial, weekly nanoparticle albumin-bound paclitaxel (w-nab-PTX) showed non-inferiority to weekly solvent-based paclitaxel (w-sb-PTX) for overall survival (OS). Thus, w-nab-PTX might be an option for second-line chemotherapy in advanced gastric cancer (AGC). However, predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashima, Atsuo, Shitara, Kohei, Fujitani, Kazumasa, Koeda, Keisuke, Hara, Hiroki, Nakayama, Norisuke, Hironaka, Shuichi, Nishikawa, Kazuhiro, Kimura, Yutaka, Amagai, Kenji, Fujii, Hirofumi, Muro, Kei, Esaki, Taito, Choda, Yasuhiro, Takano, Toshimi, Chin, Keisho, Sato, Atsushi, Goto, Masahiro, Fukushima, Norimasa, Hara, Takuo, Machida, Nozomu, Ohta, Manabu, Boku, Narikazu, Shimura, Masashi, Morita, Satoshi, Koizumi, Wasaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315007/
https://www.ncbi.nlm.nih.gov/pubmed/29855738
http://dx.doi.org/10.1007/s10120-018-0838-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315007/
https://www.ncbi.nlm.nih.gov/pubmed/29855738
http://dx.doi.org/10.1007/s10120-018-0838-6

Ejemplares similares